港股公告掘金 | 远大医药全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点

智通财经

05-06

【重大事项】：

复星国际(00656)出售葡萄牙里斯本 ENTRECAMPOS 项目中A2及A3幢大楼的部分未来单元

远大医药(00512)全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点

狮腾控股(02562)与字节跳动旗下BytePlus达成战略合作共同扩展亚太地区企业人工智能应用市场

太古股份公司：拟分拆TCPCL并于泰国证券交易所独立上市

领航医药生物科技(00399)拟与 Conflux就区块链的相关基础设施及共通关键技术进行深入合作

【财务数据】：

德视佳(01846)一季度进行的眼科手术总数为6997例，同比减少约3%

富智康集团(02038)一季度溢利107.2万美元，同比扭亏为盈

【股份回购】：

汇丰控股(00005)拟回购总值最多30亿美元股份

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2533655271"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533655271\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2533655271?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-05-06 23:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533655271","market":"us","top_or_hot":-1,"title":"港股公告掘金 | 远大医药全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点","media":"智通财经","content":"<html><body><p><strong>【重大事项】：</strong></p><p><a href=\"https://laohu8.com/S/00656\">复星国际</a>(00656)出售葡萄牙里斯本 ENTRECAMPOS 项目中A2及A3幢大楼的部分未来单元</p><p><a href=\"https://laohu8.com/S/00512\">远大医药</a>(00512)全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点</p><p><a href=\"https://laohu8.com/S/02562\">狮腾控股</a>(02562)与字节跳动旗下BytePlus达成战略合作共同扩展亚太地区企业人工智能应用市场</p><p>太古股份公司：拟分拆TCPCL并于泰国证券交易所独立上市</p><p><a href=\"https://laohu8.com/S/00399\">领航医药生物科技</a>(00399)拟与 Conflux就区块链的相关基础设施及共通关键技术进行深入合作</p><p><strong>【财务数据】：</strong></p><p><a href=\"https://laohu8.com/S/01846\">德视佳</a>(01846)一季度进行的眼科手术总数为6997例，同比减少约3%</p><p><a href=\"https://laohu8.com/S/02038\">富智康集团</a>(02038)一季度溢利107.2万美元，同比扭亏为盈</p><p><strong>【股份回购】：</strong></p><p>汇丰控股(00005)拟回购总值最多30亿美元股份</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股公告掘金 | 远大医药全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股公告掘金 | 远大医药全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-06 23:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1289893.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【重大事项】：复星国际(00656)出售葡萄牙里斯本 ENTRECAMPOS 项目中A2及A3幢大楼的部分未来单元远大医药(00512)全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点狮腾控股(02562)与字节跳动旗下BytePlus达成战略合作共同扩展亚太地区企业人工智能应用市场太古股份公司：拟分拆TCPCL并于泰国证券交易所独立上市领航医药生物科技...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1289893.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HSBA.UK","symbol_name":"汇丰控股有限公司","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1289893.html","article_id":"2533655271","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533655271","pubTimestamp":1746543685,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【重大事项】：复星国际(00656)出售葡萄牙里斯本 ENTRECAMPOS 项目中A2及A3幢大楼的部分未来单元远大医药(00512)全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点狮腾控股(02562)与字节跳动旗下BytePlus达成战略合作共同扩展亚太地区企业人工智能应用市场太古股份公司：拟分拆TCPCL并于泰国证券交易所独立上市领航医药生物科技","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"HSBA.UK":"汇丰控股有限公司","BK1572":"香港银行股","00005":"汇丰控股","LU0540923850.HKD":"ALLIANZ HONG KONG EQUITY \"A\" (HKD) INC","LU1481107354.HKD":"HSBC GIF HONG KONG EQUITY \"AD\" (HKD) INC","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","BK1191":"制药","LU0149721374.USD":"HSBC GIF HONG KONG EQUITY \"AD\" INC","BK1610":"ETF&股票定投概念","00656":"复星国际","HSBC":"汇丰","BK1230":"工业集团企业","LU0164880469.USD":"HSBC GIF HONG KONG EQUITY \"AC\" ACC","BK1601":"香港本地股","HSTECH":"恒生科技指数","LU0516422440.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"A\" (USD) ACC","00512":"远大医药","LU0516422366.SGD":"Fullerton Lux Funds - Asia Focus Equities A Acc SGD","HSHD.SI":"HSBC HK SDR 5to1","YANG":"三倍做空富时中国ETF-Direxion","03143":"华夏香港银行股","LU0634319403.HKD":"ALLIANZ HONG KONG EQUITY \"AT\" (HKD) ACC","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","BK4614":"Manus概念股","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","HSCEI":"国企指数","BK1231":"综合性银行","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC"},"translate_title":"Hong Kong stock announcement Nuggets Grand Pharmaceutical's global innovative product STC3141 successfully reached the clinical endpoint in phase II clinical study in China for the treatment of sepsis","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00005":0.9,"00512":1,"00656":0.9,"03143":0.6,"HSBA.UK":0.6,"HSBC":0.6,"HSCEI":1,"HSHD.SI":0.6,"HSTECH":1,"YANG":1},"content_text":"【重大事项】：复星国际(00656)出售葡萄牙里斯本 ENTRECAMPOS 项目中A2及A3幢大楼的部分未来单元远大医药(00512)全球创新产品 STC3141 在中国开展的用于治疗脓毒症的 II 期临床研究成功达到临床终点狮腾控股(02562)与字节跳动旗下BytePlus达成战略合作共同扩展亚太地区企业人工智能应用市场太古股份公司：拟分拆TCPCL并于泰国证券交易所独立上市领航医药生物科技(00399)拟与 Conflux就区块链的相关基础设施及共通关键技术进行深入合作【财务数据】：德视佳(01846)一季度进行的眼科手术总数为6997例，同比减少约3%富智康集团(02038)一季度溢利107.2万美元，同比扭亏为盈【股份回购】：汇丰控股(00005)拟回购总值最多30亿美元股份","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}